Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-11

Clinical Trial Update: An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 open-label trial evaluating whether early skin barrier protection can reduce the development of atopic dermatitis; the study has completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oregon Health and Science University | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2017-07-11